Lymphoma Serum
About: Lymphoma Serum - Human serum samples collected from clinically confirmed lymphoma donors. Ideal for the detection of tumor markers and inflammatory mediators.
| Lot Number | Condition | Volume | Race/Ethnicity | Age | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| 75948 | Lymphoma | 1.0 ML | Hispanic/Latino | 82 | Female | 6 | $667.00 | |||
| 75944 | Lymphoma | 1.0 ML | Hispanic/Latino | 77 | Female | 3 | $667.00 | |||
| 75947 | Lymphoma | 1.0 ML | Hispanic/Latino | 69 | Female | 2 | $667.00 | |||
| 75946 | Lymphoma | 1.0 ML | Hispanic/Latino | 54 | Female | 3 | $667.00 | |||
| 75945 | Lymphoma | 1.0 ML | Hispanic/Latino | 73 | Female | 3 | $667.00 | |||
| 53736 | Lymphoma | 1.0 ML | Caucasian | 44 | Female | United States (US) |
rexulti 2 mg QD prozac 10 mg and 20 mg QD buspar 20 mg BID Ocrevus on schedule
|
1 | $667.00 |
Human Lymphoma Serum for Research
Our Lymphoma Serum is sourced from IRB-consented donors clinically diagnosed with lymphoma. Each sample is processed and frozen within 24 hours of collection to ensure consistency and high quality for assessing systemic effects of lymphoma.
Product Features
- Collected from clinically confirmed lymphoma donors
- Research Use Only (RUO)
- IRB-approved protocols with documented consent
De-identified Donor Data
- Diagnosis confirmation
- Age, sex assigned at birth, and ethnicity
- Donor-reported allergy and infectious disease history
Applications
- Biomarker discovery for lymphoma
- Serum cytokine and protein profiling
- Therapeutic candidate screening and validation
Compliance and Quality Assurance
- IRB-approved and HIPAA-compliant protocols
- Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
- Documentation support available for regulatory review
Ordering and Customization
Lymphoma serum is available in standard and custom volumes. For international orders or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations.
Protocols & Documentation
-
Download
Serum Isolation
Protocol for serum preparation from whole blood, including collection handling, clarification, and quality documentation.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
Serum
Frequently Asked Questions
1 Answer
All our samples have self-reported infectious disease testing and verified clinical diagnosis. Many of our samples have the option of electronic medical records provided and our prospective collection offers the opportunity for patient reported outcomes and surveys. Learn more here. https://sanguinebio.com/patient-reported-outcomes-pro-surveys-questionnaires/
1 Answer
YES – Certificate of analysis is available upon request.
1 Answer
Lead times vary from ready to ship inventory to prospective studies.
1 Answer
International shipping is available. We also work with a number of distributors. Contact us to discuss options at learnmore@sanguinebio.com.
1 Answer
We have several ordering methods. You can order directly online with a PO or credit card or contact us to have a sales specialist help with your order. https://sanguinebio.com/request-quote/
1 Answer
You can request a quote on this page or contact us at learnmore@sanguinebio.com. https://sanguinebio.com/request-quote/
1 Answer
NO – no minimum order requirements.
1 Answer
For bulk pricing inquiries, please contact: LearnMore@sanguinebio.com
1 Answer
YES – You can specify inclusion/exclusion criteria including geographic location.
1 Answer
YES – You can request serum from the same lot as previously purchased. We also have the option for donor recallability.
1 Answer
YES – Healthy controls and matched samples across multiple matrices are available.
1 Answer
Our serum aliquots are generally 1 mL, but custom aliquots are available or multiple 1 mL aliquots from same donor. You can also specify unique donors for each aliquot.
Ask a Question
Need a custom Serum cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.